Durlaza News (Page 2)

FDA Approves Durlaza (aspirin) ER Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

New Haven, CT, September 8th, 2015 – New Haven Pharmaceuticals, Inc. a privately held specialty pharmaceuticals company, today announced that the U.S. Food and Drug Administration (FDA) has approved D...